Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301193 · ClinicalTrials.gov registry record
Evaluation of Novel Point of Care Coagulation System in Pregnant Women
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 13
- Enrollment target
NCT04301193: Completed study, sponsored by University of Maryland, Baltimore.
NCT04301193 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04301193 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
Primary Outcome
The Fibrinogen level of the patient in mg/dL is reflected by CS (clost strength measured in hPa) and FCS (Fibrinogen Contribution for Clot Stiffness measured by Quantra measured in hPa). CS and FCS are Quantra measurements of blood clot strength. The higher the CS and FCS, the stronger the clot and the higher the fibrinogen in the blood. Whole blood samples from pregnant women were diluted with saline to obtain various levels of fibrinogen. The diluted samples were reconstituted with plasma to
Interventions
- DEVICE Quantra Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2020-07-31 |
What the finished NCT04301193 record still lists
NCT04301193 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra Analyzer is the first listed.
NCT04301193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04301193 about?
NCT04301193 is a clinical study titled "Evaluation of Novel Point of Care Coagulation System in Pregnant Women". In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
What is the current status of trial NCT04301193?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2019-11-01. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT04301193?
The interventions under investigation include: Quantra Analyzer (DEVICE).
Who is sponsoring clinical trial NCT04301193?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI